Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RUN domain-containing protein 3B (RUNDC3B) is a protein characterized by an N-terminal RUN domain, a motif known to mediate protein–protein interactions, often in small GTPase signaling pathways. It is also referred to as Rap2-interacting protein 9, indicating potential involvement in Rap2-mediated signal transduction. While its precise biological and disease roles are not well characterized in the literature, its domain structure suggests a function related to signaling or scaffold activities within cellular pathways rather than established enzyme, receptor, or transporter roles[1]. There is no evidence from current sources that it is a direct therapeutic target or that drugs are known to interact with it.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RUN domain-containing protein 3B (RUNDC3B).